Paper 3 - Schizophrenia Flashcards
Define Positive symptoms of Sz
Positive symptoms: these are additional to normal life experiences and concern losing touch with reality (e.g. Hallucinations and Delusions)
Define Negative symptoms of Sz
Negative symptoms: Loss of usual abilities and experiences, loss of pleasure in life,
inappropriate emotional responses to situations and thought processes. (e.g. Alogia and Avolition)
4 symptoms of Sz
Hallucinations
Delusions
Alogia (speech poverty)
Avolition
Explain hallucinations as a symptom of Sz
Hallucinations: Auditory/Visual-
Usually take the form of hearing voices that are not there. These voices are normally critical and unfriendly. Additionally, some people with schizophrenia may also see,
smell, taste and feel things that are not there.
Explain delusions as symptoms of Sz
Delusions: An unshakable belief in something that is very unlikely, bizarre or obviously untrue. One of the delusions experienced in schizophrenia is paranoid delusions, where an individual believes that something, or someone, is deliberately trying to mislead, manipulate, hurt or, in some cases, even kill them. Another common delusion is the delusion of grandeur. An individual believes that they have some imaginary power or authority, such as thinking that they are on a mission from God or that they are a secret agent.
Explain alogia/speech poverty as a symptom of Sz
Alogia (Speech Poverty): When a person loses their ability to speak fluently
(reduction in the amount of quality speech).
There can also be a noticeable delay in verbal responses
during conversation. Poor amount of coherent speech.
Explain avolition as a symptom of Sz
Avolition: Apathy, where people with schizophrenia have a lack of
motivation.
Results in low activity levels therefore do not to follow through
any plans/goals and neglect household chores, such as
washing the dishes or cleaning their clothes, or maintaining
personal hygiene. Loss of persistence in work/education.
Difference between positive and negative
Positive symptoms are feelings or behaviours that are not usually present and include:
+ Delusions
+ Hallucinations
+ Catatonic or Disorganised Behaviour
+ Disorganised Speech (word salad)
Negative symptoms on the other hand refer to abilities that the patient has lost or can no longer perform and include:
- Affective Flattening
- Anhedonia
- Avolition
- Alogia (speech poverty)
More symptoms on docs (diagnosis of Schizophrenia)
Difference between classification and diagnosis
Classification is the systems used to list symptoms.Symptoms are grouped accordingly to mental disorders.Schizophrenia should have a distinct set of symptoms from other disorders.
Diagnosis is giving a person the label ‘schizophrenia.’ Generally need 2+ symptoms for ONE month or more
Important to get the labels right because of issues with stigmas and getting the right
treatment.
Classification : Rosenhan (being sane in insane places) - aim procedure findings conclusion
Aim : To investigate whether psychiatric labels would be used in situations where they weren’t appropriate. To investigate the experience of being hospitalised in a psychiatric ward.
Procedure : Rosenhan used 8 students as his ppts. These ppts were told to fake a singular symptom (hearing voices saying hollow, empty, thud). These were then admitted to 12 psychiatric hospitals in 8 states. Once admitted they stopped faking symptoms (act ‘normal’) and acted to be released because they felt fine.
Findings : 11/12 diagnosed as schizophrenia in remission (meaning they are recovering from Sz). None were ever detected as being pseudo patients (fakers) and the longest stay was two months.
Conclusion : Psychiatric labels were used in situations where they weren’t appropriate. Diagnosis isn’t reliable/accurate or consistent.
Classification : DSM-V
⦿ The Diagnostic and Statistical Manual of Mental Disorder (Edition 5), was last published in 2013.
⦿ The DSM is produced by the American Psychiatric Association.
⦿ It is the most widely used diagnostic tool in psychiatric institutions throughout America and some parts of Europe.
One positive symptom
Continuous sign of disturbance for six months with symptoms present for at least one month
Focuses on Sz as a spectrum disorder (as it features a range of symptoms that may change over time).
Classification : ICD-10
⦿ International Statistical Classification of Diseases (known as ICD)- produced in Europe by the World Health Organisation (WHO) Currently in it’s 11th edition.
⦿ Used in the UK and many other European countries
Currently refer to ICD-10 due to 11 not being used for diagnosis until 2022 (ICD - 10 used on spec)
Two or more negative symptoms
Symptoms present for one month
Recognises seven sub-types of Sz
Classification : A03 : Good Reliability
Strength
Good Reliability - A reliable diagnosis is consistent between clinicians (inter-rater) and between occasions (test-retest).
Osorio et al (2019) report excellent reliability for Sz diagnosis (DSM-5) – inter-rater agreement of +.97 and test-retest reliability of +.92. This means that the diagnosis of Sz is consistently applied.
Classification : A03 : Low Validity
Weakness
Low validity - Criterion validity involves seeing whether different procedures used to assess the same individuals arrive at the same diagnosis.
Cheniaux et al. (2009) had two psychiatrists independently assess the same 100
clients. 68 were diagnosed with Sz using ICD and 39 using DSM. This means that Sz is either over- or under-diagnosed, suggesting that criterion validity is low.
However, Osiorio found excellent agreement between clinicians using different
procedures both derived from the DSM system – this means that criterion validity
for Sz is good provided it takes place within a single diagnostic system.
Classification : A03 : Co morbidity
Weakness
Co-morbidity - If conditions often co-occur then they might be a single condition. Sz is commonly diagnosed with other conditions. For example, Buckley et al (2009) concluded that Sz is co-morbid with depression (50% of cases), substance abuse (47%) or OCD (23%). This suggests that Sz may not exist as a distinct condition.
Classification : A03 : Symptom Overlap
Weakness
Symptom overlap - There is an overlap between the symptoms of Sz and other conditions e.g. both Sz and bipolar disorder involve delusions and avolition. Sz and bipolar disorder may be the same condition (a classification issue). Sz is hard to distinguish from bipolar disorder (a diagnosis issue). This means that Sz may not exist as a condition and, if it does, it is hard to diagnose.
Classification : A03 : Gender Bias
Weakness
Gender bias - Men are diagnosed with Sz more often than women in a ratio of 1.4:1
(Fischer and Buchanan 2017). This could be because men are more genetically vulnerable, or women have better social support, masking symptoms. This means that some women with Sz are not diagnosed so miss out on helpful treatment.
Classification : A03 : Cultural Bias
Weakness
Culture bias - Some symptoms e.g. hearing voices, are accepted in some cultures, e.g. Afro-Caribbean societies ‘hear voices’ from ancestors. Afro-Caribbean British men are up to ten times more likely to receive a diagnosis as white British men, probably due to over interpretation of symptoms by UK psychiatrists. This means that Afro-Caribbean men living in the UK appear to be discriminated against by a culturally-biased diagnostic system.
Define comorbidity and symptom overlap
Co-morbidity : Two or more different disorders at the same time.
Symptom Overlap : Symptoms of one disorder are also symptoms of another disorder making it difficult to diagnose.
Biological Explanation : Genetic Basis : Gottesman (1991) twin study & conclusion
Twin: Gottesman (1991) MZ twins 48%, DZ 17% - shows a genetic element.
Conclusion = There is a genetic element to developing schizophrenia as identical twins (Mz with 100% same genes) have a concordance rate of 48% whereas fraternal twins (Dz with 50% same genes) have a concordance rate of 17%. However if it was only based on genes, identical twins (Mz) would have a 100% concordance rate, not 48%.
Biological Explanation : Genetic Basis : genetic explanation
Genetic explanation - trying to find a gene responsible for causing schizophrenia (if found it could lead to early detection and prevention of schizophrenia)
Biological Explanation : Genetic Basis : Adoption (Tienari 2004)
Adoption: Separates genetics from environment, Tienari (2004), found 6.7% of adoptees with a biological mother with schizophrenia. This suggests that it’s still based on genetic as 6.7% is higher then 1% chance which is the rate for general population.
Biological Explanation : Genetic Basis : candidate gene
Candidate Gene: There is NOT a ‘schizophrenia gene’ but SEVERAL genes are
involved (CANDIDATE GENES). Schizophrenia is polygenic and aetiologically heterogeneous. Ripke et al (2014) conducted a HUGE study using previous data
comparing 37,000 patients data with 113,000 controls and 108 genetic variations associated with increased risk of developing schizophrenia were identified. Many coded for the dopamine neurotransmitter.
Biological Explanation : Genetic Basis : Mutation
Mutation: Sz can have a genetic origin without a family history due to a mutation in parental DNA. Evidence comes from Brown et al (2002) who found a correlation between paternal age (associated with increased risk of sperm mutation) and risk of Sz.
Biological Explanation : Explain Neural correlates
Structural and functional brain abnormalities. Neural correlates are measurements of the structure or function of the brain that correlate with the positive or negative symptoms of schizophrenia.
Biological Explanation : Neural Correlates : Hyperdopaminergia
The dopamine hypothesis
Hyperdopaminergia - original view = too much dopamine in the subcortex! Central areas of the brain including Broca’s area (responsible for speech production) – associated with positive symptoms such as hallucinations & delusions BUT also speech poverty.
Biological Explanation : Neural Correlates : Hypodopaminergia
Hypodopaminergia - recent view = too little dopamine in the cortex! The prefrontal cortex (responsible for thinking & decision making) – associated with negative symptoms such as avolition.
They both have worth and could both be correct BUT antipsychotics support the original view by reducing dopamine activity by blocking receptors (Tauscher et al, 2014)!
Biological Explanation : Neural Correlates : Parkinson’s Disease
Dopamine levels in a Parkinson’s sufferer is low. L-dopa raises DA activity
People with Parkinson’s develop schizophrenic symptoms if they take too much L-dopa.
Chlorpromazine (given to schizophrenics) reduces the symptoms by blocking D2 receptors.
Biological Explanation: Genetic strength
Strong evidence base
▪ Gottesman (1991) family study shows how genetic similarity and shared risk of schizophrenia are closely related.
▪ Adoption studies Tienari (2004), show biological children of people with schizophrenia are still at heightened risk of schizophrenia even if adopted into a family without a history of schizophrenia.
▪ Hiker et al (2018) – 33% concordance for Mz and 7% for Dz twins
▪ This shows that some people are more vulnerable to sz because of their genes
Biological Explanation: Genetic weakness
Evidence for environmental risk factors
▪ Biological risk factors include birth complications (Morgan et al 2017) and smoking THC-rich cannabis in teenage years (Di Forti et al 2015)
▪ Psychological risk factors include childhood trauma e.g. 67% with Sz (38% matched controls) reported at least one childhood trauma (Morkved et al 2017)
▪ This means that genes alone cannot provide a complete explanation for Sz
Biological Explanation: Neural strength
Support for dopamine
▪ Tauscher et al (2014) also showed antipsychotics that reduce DA also reduce intensity of symptoms
▪ Amphetamines increase DA and mimic Sz symptoms (Curran et al 2004)
▪ This strongly suggests that dopamine is involved in the symptoms of Sz
Biological Explanation: Neural weakness
Evidence for a central role of glutamate
▪ Post-mortem and live scanning studied have consistently found raised levels of the neurotransmitter glutamate in several brain regions (McCutheon et al. 2020)
▪ Several candidate genes are believed to be involved in glutamate production or processing
▪ Therefore there is evidence of other neurotransmitter being involved and not just dopamine
Biological Explanation : General Weakness
This explanation is reductionist as it reduces a complex disorder like schizophrenia to a basic cellular and chemical level which therefore does not recognise the gender and culturally differences that occur.
▪ If it was purely genetic, MZ concordance should be 100%. However MZ twins are usually reared in the same environments, therefore treated the same compared to DZ, so it may be social learning theory (imitation through observation) that causes
schizophrenia. Therefore we cannot disentangle the environmental influences from biological causes.
Biological treatment : Typical Antipsychotics (chlorpromazine)
Typical Antipsychotics (1950s)
▪ Chlorpromazine combat the positive symptoms of schizophrenia. They are dopamine antagonists; they bind to dopamine receptors, without stimulating them, blocking the action of dopamine receptors in the synapse. This reduces the action of dopamine.
▪ Hallucinations and delusions diminish within a few days.
▪ Chlorpromazine also has an effect on histamine receptors which lead to a sedation effect – used to calm anxious patients when they are first admitted to hospital.
Biological treatment : Typical Antipsychotics (pimozide)
▪ Pimozide is another typical antipsychotic that works by decreasing the activity of dopamine in the brain